Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Trubion Pharmaceuticals Logo
Trubion Pharmaceuticals Growth Score
69
CB Rank
3252347
Heat Score
12
Trubion Pharmaceuticals is a biopharmaceutical company creating a pipeline of product candidates to treat autoimmune disease and cancer.
Acquired by
Emergent BioSolutions Logo
Emergent BioSolutions
Founded
obfuscation
DelistedPost-IPO Equity Seattle, Washington, United States101-250 www.trubion.com/
Biotechnology
Health Care
Pharmaceutical
Therapeutics
Overview

Trubion Pharmaceuticals
Total Funding
obfuscation
Growth Score
69
Heat Score
12

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score69
-8 pts
in past quarter
Heat Score 12
-11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Trubion Pharmaceuticals

CB Rank
3252347
Trubion Pharmaceuticals is a biopharmaceutical company creating a pipeline of product candidates to treat autoimmune disease and cancer.
Acquired by
Emergent BioSolutions Logo
Emergent BioSolutions
Founded
obfuscation
DelistedPost-IPO Equity Seattle, Washington, United States101-250 www.trubion.com/
Biotechnology
Health Care
Pharmaceutical
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Details

Legal Name Trubion Pharmaceuticals, Inc
Also Known As Trubion Pharmaceuticals Inc.
Operating Status Active
Stock Symbol  NASDAQ:TRBN
Company Type For Profit
Founders  Peter Thompson
About the Company
Trubion Pharmaceuticals is a biopharmaceutical company creating a pipeline of product candidates to treat autoimmune disease and cancer. Our product candidates are novel proteins known as single-chain polypeptides and are designed using our SMIPTM custom drug assembly technology.
Predictions & Insights

Products & Services

MicroMolar EDTA Assay Kit
An analytical kit for precise quantification of EDTA at micromolar levels in various sample types using colorimetric detection.
Glycosylation Profiling with Mass Spectrometry
A method using mass spectrometry to analyze glycan structures attached to proteins, aiding drug development and bioconjugation research.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Trubion Pharmaceuticals Logo
Post-IPO Equity - Trubion Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Trubion Pharmaceuticals Logo
Post-IPO Equity - Trubion Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Trubion Pharmaceuticals Logo
Post-IPO Equity - Trubion Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Trubion Pharmaceuticals Logo
Post-IPO Equity - Trubion Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Trubion Pharmaceuticals Logo
Post-IPO Equity - Trubion Pharmaceuticals
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Trubion Pharmaceuticals Logo
Post-IPO Equity - Trubion Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Trubion Pharmaceuticals Logo
Post-IPO Equity - Trubion Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Trubion Pharmaceuticals Logo
Post-IPO Equity - Trubion Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Trubion Pharmaceuticals Logo
Post-IPO Equity - Trubion Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Trubion Pharmaceuticals Logo
Post-IPO Equity - Trubion Pharmaceuticals
—
obfuscation
— Post-IPO Equity

Investors

M&A Details

Trubion Pharmaceuticals was acquired by Emergent BioSolutions for
obfuscation
on
obfuscation
.
Transaction Name 
Trubion Pharmaceuticals acquired by Emergent BioSolutions Logo
Trubion Pharmaceuticals acquired by Emergent BioSolutions
Acquired by 
Emergent BioSolutions Logo
Emergent BioSolutions
Announced Date 
obfuscation
Price 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Board Members and Advisors 1

Board Members and Advisors

News

News and Press

News•Aug 28, 2009
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 26, 2008
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Interest Signals

TopicSurge Score
Market Day Supply Logo
Market Day Supply
79
Market Capitalization Logo
Market Capitalization
77
Task Management Logo
Task Management
76

Active Website Tech Count

3Trubion Pharmaceuticals is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  COVID-19.

Total IP

8The intellectual property of Trubion Pharmaceuticals includes 8 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Trubion Pharmaceuticals's headquarters? Trubion Pharmaceuticals is located in Seattle, Washington, United States.Who invested in Trubion Pharmaceuticals? Trubion Pharmaceuticals has 6 investors including Prospect Venture Partners and  Oxford Bioscience Partners.When was the last funding round for Trubion Pharmaceuticals? Trubion Pharmaceuticals closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Trubion Pharmaceuticals's competitors? Alternatives and possible competitors to Trubion Pharmaceuticals may include Mirna Therapeutics, CD BioGlyco, and  Redasoft.How much funding has Trubion Pharmaceuticals raised to date? Trubion Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f8e1fc8 1)
|